Hong Kong researchers develop ‘world-first’ nasal spray for rapid stroke aid

AI Summary

Researchers from the University of Hong Kong have announced a groundbreaking nasal spray designed to provide immediate first aid for ischemic stroke patients. Clinical trials are expected to begin by 2030, aiming to make it widely available in pharmacies.

Researchers at the University of Hong Kong (HKU) say they have developed a world-first nasal spray that delivers neurotherapeutic powder directly to the brain as first aid for ischemic stroke patients, with clinical trials expected by 2030. The treatment is intended for initial use by paramedics, before being rolled out to high-risk groups in care facilities and eventually the general public through pharmacies. It was developed by the Li Ka Shing Faculty of Medicine at HKU and the university’s...